241 | Add to Reading ListSource URL: circabc.europa.euLanguage: English |
---|
242 | Add to Reading ListSource URL: www.alzdiscovery.orgLanguage: English - Date: 2015-01-20 13:00:56
|
---|
243 | Add to Reading ListSource URL: www.aihealthsolutions.caLanguage: English - Date: 2015-01-06 11:34:23
|
---|
244 | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
245 | |
---|
246 | SOP[removed]Annex C 20, avenue Appia – CH-1211 Geneva 27 – Switzerland – Tel central +[removed] – Fax central +[removed]www.who.int WHO PUBLIC INSPECTION REPORTAdd to Reading ListSource URL: apps.who.intLanguage: English - Date: 2014-12-15 08:39:22
|
---|
247 | EMA/CMDh EXPLANATORY NOTES ON VARIATION APPLICATION FORM (Human medicinal products only) Doc. Ref.: CMDh/EMA[removed]Rev6Rev.7 July 2013Add to Reading ListSource URL: www.hma.euLanguage: English - Date: 2014-12-11 13:02:50
|
---|
248 | EMA/CMDh EXPLANATORY NOTES ON VARIATION APPLICATION FORM (Human medicinal products only) Doc. Ref.: CMDh/EMA[removed]Rev.7 December 2014Add to Reading ListSource URL: www.hma.euLanguage: English - Date: 2014-12-11 13:19:54
|
---|
249 | Ossianix Expands and Extends its Research Collaboration with Lundbeck on CNS Therapeutics 16 December 2014 PHILADELPHIA, PA: Ossianix, Inc. today announced an expansion and extension of its strategic research collaboratiAdd to Reading ListSource URL: www.bioadvance.comLanguage: English - Date: 2014-12-17 09:48:59
|
---|
250 | Frequently Asked Questions Canadian Clinical Trials Asset Map (CCTAM) 1. What is the CCTAM? The CCTAM will be a robust, online, searchable database designed to communicate Canada’s clinical research strengths to all stAdd to Reading ListSource URL: www.cctam.caLanguage: English - Date: 2014-12-18 13:58:52
|
---|